Pharma's Almanac

2950 Articles Available

1 123

Clinical Trials

Almac Group Announces Almac One™ - a Unified Clinical Trial Supply Solution

PR-M03-19-NI-026

Drug Safety

BioIVT Launches Its XPRESSWAY® Profile Safety Package, a Gene Expression Reference Guide Designed to Improve Drug Safety Analyses

PR-M03-19-NI-024

Clinical Trials

AOBiome Doses First Patient in Phase 1b Clinical Trial of B244 for the Treatment of Pediatric Atopic Dermatitis

PR-M03-19-NI-022

Acquistion

Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.

PR-M03-19-NI-023

R&D

Leading Global R&D-Based Pharmaceutical Company Chooses ValGenesis's VLMS to Manage Validation Process

PR-M03-19-NI-021

FDA

Lilly Receives FDA Priority Review Designation for Emgality® (galcanezumab-gnlm) Injection for the Preventive Treatment of Episodic Cluster Headache in Adults

PR-M03-19-NI-017

ANDA

Perrigo Confirms Patent Challenge for Generic Version of Nascobal®

PR-M03-19-NI-020

FDA Approval

NKMax America Announces FDA Approval of IND for Phase 1 Trial of SNK01 in Patients with Refractory Cancer

PR-M03-19-NI-018

Clinical Trials

Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study

PR-M03-19-NI-016

Healthcare

The First WuXi Healthcare Forum Opens in Shanghai

PR-M03-19-NI-019

Market Prediction

Over-the-Counter Drugs Market to Hit $185 Billion by 2025: Global Market Insights Inc.

PR-M03-19-NI-015

Clinical Trials

BioPharmX Completes Enrollment in Phase 2b Trial of BPX-04 for Patients with Papulopustular Rosacea

PR-M03-19-NI-014

Research

Mallinckrodt Presents Data on Cutaneous T-cell Lymphoma at 2019 American Academy of Dermatology Annual Meeting

PR-M03-19-NI-013

Drug Pricing

Diabetes Patients Look Forward to Lower-Priced Insulin

PAO-M03-19-NI-015

Acquisition

Biogen Moves into Gene Therapy with Nightstar Buy

PAO-M03-19-NI-014

Cell and Gene Therapy

Precision BioSciences Aims for Significant Funding Support based on its ARCUS Gene Editing Tech

PAO-M03-19-NI-013

Drug Pricing

How Do You Classify Fecal Microbiota?

PAO-M03-19-NI-012

M&A

Big Deals Already Begun for Biotechs in 2019

PAO-M03-19-NI-011

Innovation

Innovative Tech Might Make Infrared Vision Possible

PAO-M03-19-NI-010

FDA

New Form of Herceptin Approved by U.S. FDA for Breast Cancer

PAO-M03-19-NI-010

Clinical Trials

Clinical Trials Bot Matches Patients to Studies

PAO-M03-19-NI-009

Drug Development

Novartis Licenses First-in-Class Heart Disease Drug

PAO-M03-19-NI-008

Drug Pricing

Senate Finance Committee Holds Hearing on Pharma Pricing

PAO-M03-19-NI-007

Gene Therapy

Roche Moves into the Gene Therapy Space

PAO-M03-19-NI-006

1 123

»